EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitScoping ReviewOpen access · CC BY 4.0

Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review

Camila Barcellos Calderipe iD, Caique Mariano Pedroso iD, Márcio Ajudarte Lopes iD, Saman Warnakulasuriya iD, Alan Roger Santos-Silva iD

Oral Diseases · 2026-11-15

DOI: 10.1111/odi.70573 ↗

At a glance

Übersichtsarbeit in Oral Diseases, published online on 2026-11-15. Written by Camila Barcellos Calderipe and 4 co-authors. Institution: Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil. 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To identify the types of cancer and the corresponding screening methods evaluated in randomized controlled trials (RCTs), with a primary focus on situating oral cancer screening within the RCT‐based body of evidence.

Methods

This review followed the PRISMA‐ScR guidelines. PubMed, Web of Science, Embase, Scopus, LILACS, ProQuest, and Google Scholar were searched without date restrictions for studies in English, Spanish, or Portuguese. Eligible studies were RCTs primarily evaluating cancer screening methods (clinical, imaging, endoscopic, laboratory, molecular/serological, or self‐examination). Data were synthesized as means and frequencies.

Results

Nine cancer types and 33 distinct screening methods were identified across 97 cancer screenings in 91 RCTs spanning 57 years. Oral cancer ranked last, with only one RCT evaluating a single method, oral visual inspection, the fewest of any cancer type. By comparison, colorectal cancer was the most frequently investigated ( n = 22/22.7%), followed by breast cancer ( n = 21/21.6%) and lung cancer ( n = 18/18.6%), with five, six, and four screening methods evaluated, respectively.

Conclusion

These findings map the RCT landscape in cancer screening, revealing marked disparities in evidence across cancer types and identifying oral cancer as the most limited. Further RCTs are urgently needed to strengthen the evidence base and support effective oral cancer screening programs.

Subjects

Author keywords

cancerrandomized controlled trialsscreening

Authors and institutions

  • Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil.
  • Faculty of Dental, Oral and Craniofacial Sciences, King's College London and WHO Collaborating Centre for Oral Cancer, London, UK.

ORCID profiles: Camila Barcellos Calderipe, Caique Mariano Pedroso, Márcio Ajudarte Lopes, Saman Warnakulasuriya, Alan Roger Santos-Silva

Funding

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Cite

APA

Calderipe, C. B., Pedroso, C. M., Lopes, M. A., Warnakulasuriya, S., & Santos-Silva, A. R. (2026). Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review. Oral Diseases. https://doi.org/10.1111/odi.70573

Vancouver

Calderipe CB, Pedroso CM, Lopes MA, Warnakulasuriya S, Santos-Silva AR. Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review. Oral Diseases. 2026. doi:10.1111/odi.70573

BibTeX
@article{Calderipe2026,
  author = {Calderipe, Camila Barcellos and Pedroso, Caique Mariano and Lopes, Márcio Ajudarte and Warnakulasuriya, Saman and Santos-Silva, Alan Roger},
  title = {Oral Cancer Screening in the Landscape of Randomized Controlled Trials: A Scoping Review},
  journal = {Oral Diseases},
  year = {2026},
  doi = {10.1111/odi.70573}
}
Start for free →